Navigation Links
ARIXTRA drug for venous thromboembolism

Venous thromboembolism is a complication causing increased bleeding which occurs after an orthopedic surgery procedure. // Professor Clifford W. Colwell has reported in the Journal of Arthroplasty that by giving a dose of ARIXTRA drug to these patients who underwent orthopedic surgery the complications and amount of bleeding decreased.

ARIXTRA drug which is called as FLEXTRA (Flexibility in Administration of Fondaparinux for Prevention of Symptomatic Venous Thromboembolism in Orthopaedic Surgery) is found to have anti-thrombotic activity which helps in coagulation by increasing the coagulating factors is found to be very useful in these patients and the drug is administered in the morning the day after surgery when the risk of developing venous thromboembolism is high.

The drug ARIXTRA is manufactured by the pharmaceutical giant GlaxoSmithKline and is found to inhibit the factor Xa protein which is present in the coagulation cascade pathway and the drug is found to effectively control venous thromboembolism and pulmonary embolism in patients who underwent bone surgery for knee and hip replacement. The drug ARIXTRA is found to have very less side effects of causing bleeding, bacterial endocarditis and hypersensitivity but the benefits of the drug is more beneficial than its side effect.


'"/>




Page: 1

Related medicine news :

1. Painkilling Patch As Effective As Intravenous Delivery Systems
2. Intravenous Vitamin C (Ascorbate) for Cancer Treatment
3. Oral use of ZYVOX (Linezolid) is better to Intravenous Vancomycin use for Skin Infections
4. The ideal composition of intravenous lipid emulsion
5. Intravenous Iron treats anemia of pregnancy faster
6. Advance in Program for Development of Non-Intravenous Therapy for Hemophilia
7. Intravenous Delivery of Clot-busting Drug Still Best Intervention for Ischemic Stroke
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's (ABFM) ... and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton ... until Dr. Puffer’s retirement at the end of 2018. Upon assuming the role of ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Lori R. ... a member of ElderCounsel, a national organization of elder law and special needs planning ... laws and rules. It also provides a forum to network with elder law attorneys ...
(Date:10/13/2017)... ... , ... Ellevate Network, the leading network for professional women, brought together some ... at their inaugural Summit in New York City in June. The event was livestreamed ... over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 /PRNewswire/ ... health and big data solutions, today announced that its MyDario product is ... your local TV listings for when The Dr. Oz Show airs in ... The nine-time ... month. ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: